IL141699A0 - Primate embryonic stem cells with compatible histocompatibility genes - Google Patents

Primate embryonic stem cells with compatible histocompatibility genes

Info

Publication number
IL141699A0
IL141699A0 IL14169999A IL14169999A IL141699A0 IL 141699 A0 IL141699 A0 IL 141699A0 IL 14169999 A IL14169999 A IL 14169999A IL 14169999 A IL14169999 A IL 14169999A IL 141699 A0 IL141699 A0 IL 141699A0
Authority
IL
Israel
Prior art keywords
compatible
stem cells
embryonic stem
primate embryonic
histocompatibility genes
Prior art date
Application number
IL14169999A
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of IL141699A0 publication Critical patent/IL141699A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/04—Cells produced using nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cell Biology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
IL14169999A 1998-09-01 1999-05-05 Primate embryonic stem cells with compatible histocompatibility genes IL141699A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9871298P 1998-09-01 1998-09-01
PCT/US1999/009784 WO2000012682A1 (en) 1998-09-01 1999-05-05 Primate embryonic stem cells with compatible histocompatibility genes

Publications (1)

Publication Number Publication Date
IL141699A0 true IL141699A0 (en) 2002-03-10

Family

ID=22270566

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14169999A IL141699A0 (en) 1998-09-01 1999-05-05 Primate embryonic stem cells with compatible histocompatibility genes

Country Status (6)

Country Link
EP (1) EP1117764A1 (en)
JP (1) JP2002523084A (en)
AU (1) AU3881499A (en)
CA (1) CA2342205A1 (en)
IL (1) IL141699A0 (en)
WO (1) WO2000012682A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
GB2386125B (en) * 2000-11-22 2005-02-23 Geron Corp Tolerizing allografts of pluripotent stem cells
DE10061334A1 (en) * 2000-12-04 2002-06-13 Max Delbrueck Centrum Use of cells derived from embryonic stem cells to increase transplant tolerance and to restore destroyed tissue
CA2433419A1 (en) * 2001-01-02 2002-07-25 Stemron, Inc. A method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same
EP1367899A4 (en) 2001-02-14 2004-07-28 Leo T Furcht Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
JP2004248505A (en) * 2001-09-21 2004-09-09 Norio Nakatsuji Undifferentiated fusion cell of somatic cell derived from es cell deficient in part or all of transplantation antigen and method for producing the same
US6759244B2 (en) 2001-11-08 2004-07-06 Art Institute Of New York And New Jersey, Inc. Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos
US20030153082A1 (en) * 2001-12-07 2003-08-14 The John P. Robarts Research Institute Hematopoietic cells from human embryonic stem cells
US7799324B2 (en) 2001-12-07 2010-09-21 Geron Corporation Using undifferentiated embryonic stem cells to control the immune system
US7462448B2 (en) 2002-08-02 2008-12-09 Stratatech Corporation Species specific DNA detection
WO2004038012A1 (en) * 2002-10-25 2004-05-06 Hunan Hui-Lin Life Technology Co. Ltd The feeder cell layer for in vitro culturing human embryonic stem cells and the method for culturing embryonic stem cells
WO2005013679A1 (en) * 2003-08-07 2005-02-17 Ivan De Weber Reproductive and non-reproductive cloning method
EP2087101A2 (en) 2006-11-24 2009-08-12 Regents of the University of Minnesota Endodermal progenitor cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63248385A (en) * 1987-04-03 1988-10-14 Kingo Yoshida Rejuvenation and life-prolongation by transplantation of juvenile cell same as aged body and infusion of aging-preventive juvenile gene
WO1995003398A1 (en) * 1993-07-23 1995-02-02 Monash University Enucleation of oocytes
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
IL128348A (en) * 1996-08-19 2008-08-07 Univ Massachusetts Method of producing embryonic or stem like cell lines by transplantation of cell nuclei from animal or mammal, such cells and uses thereof
US5945577A (en) * 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
DE19709549A1 (en) * 1997-03-07 1998-09-24 Eberhard Prof Dr Born Modified mammalian egg cell for implantation contains nucleus from implant recipient

Also Published As

Publication number Publication date
JP2002523084A (en) 2002-07-30
CA2342205A1 (en) 2000-03-09
EP1117764A1 (en) 2001-07-25
AU3881499A (en) 2000-03-21
WO2000012682A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
IL142748A0 (en) Embryonic stem cells
EP0770125A4 (en) Primate embryonic stem cells
IL141393A0 (en) Enzymatic battery
IL141699A0 (en) Primate embryonic stem cells with compatible histocompatibility genes
GB2334965B (en) A cell culture vessel
AU6842001A (en) Pluripotent mammalian cells
HK1046062A1 (en) Alkaline cell with insulator
EP1333086A4 (en) Cell culture case
HUP0200394A3 (en) Fucosyl transferase gene
GB9904905D0 (en) Cells
HUP0105168A3 (en) Transplantation of haematopoietic cells
GB9813757D0 (en) Integral fuel cell
EP1156105A4 (en) Novel enzyme
GB9925161D0 (en) Novel enzyme
EP1128451A4 (en) Cell
HUP0501094A2 (en) Somatic cell derived embryonic stem cells and its differentiated cells
AU4974800A (en) Eosinophil degranulating conditions
TW461382U (en) Knock type automatic writing implement
AUPQ285299A0 (en) Embryonic stem cells
SG87791A1 (en) Leak-resistant container
EP1218036A4 (en) Cell based assay
AUPP700998A0 (en) Embryonic stem cells
GB9801153D0 (en) Anaerobic culturing
GB9822434D0 (en) Mesenchymal precursor cells
GB0228988D0 (en) Retention assembly